Leaflet MANNITOL VIOSER 20g / 100ml solution for infusion


Indicated for: cerebral edema; edema; bronchial challenge test

Route of administration: infusion

Substance: mannitol (osmotic agent)

ATC: B05BC01 (Blood and blood forming organs | I.v. solutions | Solutions producing osmotic diuresis)

Mannitol is an osmotic diuretic primarily used to reduce intracranial and intraocular pressure. It is commonly used in emergency situations such as traumatic brain injuries or cerebral edema.

It works by increasing the excretion of water and electrolytes through the kidneys, thereby reducing fluid volume in the body. Mannitol is administered intravenously under medical supervision.

Side effects may include electrolyte imbalances, dehydration, or allergic reactions. It is important to monitor kidney function and electrolyte levels during treatment.

Mannitol is not recommended for patients with severe renal failure, severe dehydration, or active intracranial hemorrhage.

General data about MANNITOL VIOSER 20g / 100ml

  • Substance: mannitol
  • Date of last drug list: 01-05-2026
  • Commercial code: W07208003
  • Concentration: 20g / 100ml
  • Pharmaceutical form: solution for infusion
  • Packing volume: 250ml
  • Product type: generic
  • Price: 83.44 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: VIOSER S.A. PARENTERAL SOLUTION INDUSTRY - GRECIA
  • Holder: VIOSER S.A. PARENTERAL SOLUTION INDUSTRY - GRECIA
  • Number: 8836/2016/03
  • Shelf life: 3 years

Concentrations available for mannitol

  • 10%
  • 150mg/ml
  • 20%
  • 200g/1000ml
  • 200g/l
  • 20g/100ml